KIF18A Inhibitor Shows Promise Against Osteosarcoma Growth
A KIF18A inhibitor has been shown to prevent growth in chromosomally unstable osteosarcoma by activating the spindle assembly checkpoint.
Asset / Drug
Drug and asset intelligence for KIF18A with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.